ArticleSurgical endoscopy2026
A comparative study of transoral and submental versus vestibular endoscopic thyroidectomy in patients with papillary thyroid carcinoma.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransoral endoscopic thyroidectomy vestibular approach (TOETVA) is widely adopted for its cosmetic advantage but is associated with postoperative oral discomfort and mental nerve injury. This study aimed to evaluate whether a modified technique, transoral and submental endoscopic thyroidectomy (TOaST), improves perioperative outcomes in patients with papillary thyroid carcinoma (PTC).
methodsA retrospective study was conducted on 136 patients with PTC who underwent either TOaST (n = 51) or TOETVA (n = 85). Key outcomes included operative time, time to oral intake, postoperative pain, swallowing function, incidence of chin numbness, complications, and cosmetic satisfaction.
resultsTOaST was associated with shorter operative time (123.05 ± 19.45 vs. 143.89 ± 22.68 min, P < 0.001), earlier oral intake (3.12 ± 0.82 vs. 5.22 ± 1.49 h, P < 0.001), and lower pain scores at 24 and 48 h (P < 0.001). Swallowing function on day 3 was better in the TOaST group (P < 0.001). Chin numbness occurred in 17.6% of TOETVA patients but none in the TOaST group (P = 0.001). Overall complication rates and cosmetic satisfaction were similar between the groups.
conclusionsTOaST demonstrates advantages in surgical efficiency, pain control, and early functional recovery without compromising aesthetic results, making it a favorable alternative to TOETVA in selected PTC patients.
Indexed as
Identifiers
41145699What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.